TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: recurrent diverticulitis
Endpoint domain: Adverse events/effects
Primary endpoint: complicated diverticulitis
Endpoint domain: Adverse events/effects
Primary endpoint: sigmoid resection
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of positive urine dipstick albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Annual changes in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HBV DNA loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for music listening method
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Disability Assessment (DA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients using antiplatelet therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improved depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammation scores in the stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: inflammation scores in the duodenum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Wound architecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Achieving <5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Objective competence improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective confidence improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful sentinel node identification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient knowledge improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stated values at 1 month
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of LVAD implantation by 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: understanding risk difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of the evidence associated with a treatment effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accessibility of information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduction in IVH volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Graeb score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAH sum score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of endocervical margin involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of residual lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of cannulation on first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Solute-free water excretion increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum sodium increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of women who agreed to participate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: No-show rate among participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Impaired color vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS after 36 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of estradiol (E2) and progesterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum level of AMH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Correct compression depth according to AHA-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct compression depth according to ERC-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: state TSF susceptibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in goal setting
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction in depression rating scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in anxiety rating scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: (123)I‐QNB uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total body tissue fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of challenge-proven CMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance to cow's milk one year after diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding knowledge and practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: comfort level of patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Staff perceptions of referral management system safety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensory gating response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Weight loss difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ghrelin increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Leptin decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: patients' disability associated with low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-week recall of warning-label text
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increased mild-moderate diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Basal HPA activity measured by 24-hr urine total glucocorticoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Dynamic HPA activity measured by plasma ACTH and serum cortisol responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Effective compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improving functional abilities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: levels of blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum prealbumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: transferrin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time until the first COPD exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization for exacerbation
Endpoint domain: Adverse events/effects
Primary endpoint: airway problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: fistula surgery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: VPI surgery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Nutritionally substantive breakfast consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk of distant metastasis
Endpoint domain: Mortality/survival
Primary endpoint: Increase of IL-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase of C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease of S-IL-2R levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: posterior change in the position of the maxilla
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: palato‐mandibular angle (PL‐ML)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: retroglossal airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IP opioid and other drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day cardiac events
Endpoint domain: Mortality/survival
Primary endpoint: Mean Effective Response (MER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systolic Index (SI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SF-36 physical function score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: blood transfusion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: indocyanine green plasma disappearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery slope of thenar muscle oxygen saturation after a vascular occlusion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lumbar spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: osteoporosis-related quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of post-MI angina pectoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of rhythm and conduction disturbance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: inflammatory lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-year incidence of nuclear opacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of norepinephrine dose rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean Arterial Pressure (MAP) sustained at >70 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall safety profile of 546C88
Endpoint domain: Adverse events/effects
Primary endpoint: levels of pain during and after phlebotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fear scores of the children before phlebotomy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fear levels during phlebotomy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Itch improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep loss improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mean total costs per patient at 2‐years follow‐up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Echolucency of the carotid intima-media
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of intracerebral hemorrhage (ICH)
Endpoint domain: Adverse events/effects
Primary endpoint: 24 h intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 h ocular diastolic perfusion pressure (DOPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-1 perinatal transmission rate
Endpoint domain: Mortality/survival
Primary endpoint: breast milk log10 HIV-1 RNA suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EEG measures indicative of arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ventricular filling rate response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stroke volume response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of hyperuricemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean concentration of plasma UA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in dry mouth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unstimulated salivary flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in harmful drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in nonhazardous drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average decrease in quantity and frequency of drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at self-management class
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Surgical-site infection, recurrent intraabdominal infection, or death
Endpoint domain: Mortality/survival
Primary endpoint: non-remission from binge eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Portal venous enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor-liver contrast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerance of human albumin treatment
Endpoint domain: Adverse events/effects
Primary endpoint: decreased numbers of CD25+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: lower intragraft IL‐2 mRNA transcription levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: proportion of graft‐infiltrating cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: risk-adjusted hospital death rates
Endpoint domain: Mortality/survival
Primary endpoint: Progression-Free Survival (PFS) at 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in sleep symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: lesion classifier accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to reach INR of 4.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children asleep 2 hours after receiving ADC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coping ability with anticipated death
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Utilization of psychosocial resources
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: overall need for rescue analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in echotypes III and IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: glucose-lowering effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Good functional outcomes at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rates of intracerebral hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of VZV reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: mean absolute change in tremor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival in the interval cancer group
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of post-ERCP abdominal pain
Endpoint domain: Adverse events/effects
Primary endpoint: Stricture development rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of total parenteral nutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-reported total physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSRQ Healthy Eating scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stages of Change scores
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Major adverse cardiac and cerebral events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: side effects with spacer delivery
Endpoint domain: Adverse events/effects
Primary endpoint: nonfasting peak concentrations of activated FVII (FVIIa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Elimination of M. gordonae infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tracking coefficients for fruit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracking coefficients for vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracking coefficients for unhealthy snacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean eruption time of PDCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous eruptions of PDCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (HQOLI-R)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptom diary score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Detection rate for CIN2+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Responder rate on the ADAS-cog
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Effect-site concentration of fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of anesthetic recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Technical success rate of drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average total cost for the 3-month episode of care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Delayed bleeding rate
Endpoint domain: Adverse events/effects
Primary endpoint: Prediction error in classifying vaginal swabs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain thresholds at the incision region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean visual acuity at 1-year follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total injections given over the treatment period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Successful placement of nasojejunal tube at 24h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: postoperative endometritis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in biomarkers of tobacco-related harm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of molar hypomineralization (MH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of MIH defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of recurrence of venous thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of major vascular events (venous thromboembolism, myocardial infarction, stroke, cardiovascular death)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: repeated births
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity to task stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of classifiers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of people healed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of bacterial load from root canals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Lowering levels of Th1-type cytokines in apical lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in levels of Th2-type cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difficulty in positioning the ET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vision quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of childhood immunizations delivered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intragastric NO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean NO2- concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes